Jaime Henson, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 300 W King St, Ste C, Littlestown, PA 17340 Phone: 717-339-2390 Fax: 717-359-4178 |
Mrs. Emily Elizabeth Boyce, MSN, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 300 W King St Ste B&c, Littlestown, PA 17340 Phone: 717-339-2390 |
Jennifer M Clark, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 300 W King St, Suite C, Littlestown, PA 17340 Phone: 717-339-2390 Fax: 717-359-4178 |
Mrs. Karen Elaine Phillips, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 W King St, Littlestown, PA 17340 Phone: 717-359-9214 Fax: 717-359-8120 |
Barbetta Ann Moffatt, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 300 W King St, Suite C, Littlestown, PA 17340 Phone: 717-339-2390 Fax: 717-359-4178 |
News Archive
Springer celebrates its 50,000th eBook, available on its online platform SpringerLink. This milestone underscores Springer's position as the largest eBook publisher and emphasizes SpringerLink's dominance in offering the world's most comprehensive online collection of science, technology and medicine (STM) journals, books and reference works.
Establishing the way in which a genetic alteration called a TMPRSS2-ERG gene fusion forms in a prostate cancer, rather than the presence of the gene fusion itself, could help identify patients with prostate cancer with a low risk of spreading, which might determine the best course of treatment for the patient.
While estimates of the overall risk of a thrombotic (blood clot) event recurrence vary, reports on contributing factors are contradictory, according to background information in the article. Knowledge of the risk of a thrombotic event recurrence and its determinants is relevant for clinical policy regarding screening for thrombophilia (increased risk for blood clot), duration of anticoagulant treatment, and treatment strategies in circumstances of increased risk.
Following extensive customer research, Chromatrap has re-designed its website to better serve the needs of end users.
› Verified 8 days ago